Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jeffrey W Taub
Inhibition of CHK1 Enhances Cell Death Induced by the BCL-2-Selective Inhibitor ABT-199 in Acute Myeloid Leukemia Cells
Oncotarget
Oncology
Related publications
Inhibition of BCL-xL Overcomes Polyploidy Resistance and Leads to Apoptotic Cell Death in Acute Myeloid Leukemia Cells
Oncotarget
Oncology
Loss in McL-1 Function Sensitizes Non-Hodgkin’s Lymphoma Cell Lines to the BCL-2-selective Inhibitor Venetoclax (ABT-199)
Blood Cancer Journal
Oncology
Hematology
Cell-Selective Oligonucleotide STAT3 Inhibitor for Immunotherapy of Human Acute Myeloid Leukemia
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Cytotoxic T Lymphocytes Promote Cytarabine-Induced Acute Myeloid Leukemia Cell Apoptosis via Inhibiting BCL-2 Expression
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Metabolic Changes Associated With Metformin Potentiates Anti-BCL-2 Inhibitor, Abt-199, and Cdk9 Inhibitor, Bay-1143572 and Reduces Viability of Lymphoma Cells
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Interferon-Gamma Enhances Radiation-Induced Cell Death via Downregulation of Chk1
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Dasatinib Accelerates Valproic Acid-Induced Acute Myeloid Leukemia Cell Death by Regulation of Differentiation Capacity
PLoS ONE
Multidisciplinary
Synergistic BCL-2 Inhibition by ABT-737 and Cyclosporine A
Apoptosis : an international journal on programmed cell death
Cell Biology
Pharmacology
Biochemistry
Clinical Biochemistry
Cancer Research
Pharmaceutical Science
Pan-BCL-2 Inhibitor AT-101 Enhances Tumor Cell Killing by EGFR Targeted T Cells
PLoS ONE
Multidisciplinary
